Maryland Community Health System
Based in MD
🤖
AI Overview
With $0 in lobbying spend across 12 quarterly filings, Maryland Community Health System is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2018 to 2020.
$0
Total Spend
3
Years Active
1
Firms Hired
1
Lobbyists Deployed
4
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $0 |
| 2019 | $0 |
| 2020 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations, Medicare/Medicaid, Pharmacy
- •Extension of funding and policy changes for Community Health Centers and the National Health Service Corps
- •FY2019 Community Health Center Appropriations
- •Funding Extension for ACA Community Health Center and National Health Service Corps
- •FY2019 Community Health Center Appropriations
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Mind Medicine (Mindmed) INC.
$370K total spend
Sickle Cell Disease Association of America
$200K total spend
Stonington Global (Obo, Maimonides Medical Center)
$75K total spend
The American Occupational Therapy Association, INC. (Aota)
$6.0M total spend
The United States Pharmacopeial Convention
$2.6M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.